Harmony Biosciences Holdings, Inc. HRMY
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-08-19
Harmony Biosciences Holdings, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 5,835,243 | $176.0M | 9.97% |
| RENAISSANCE TECHNOLOGIES LLC | 1,077,371 | $30.2M | 1.84% |
| MILLENNIUM MANAGEMENT LLC | 954,359 | $26.7M | 1.63% |
| TWO SIGMA INVESTMENTS, LP | 733,443 | $20.5M | 1.25% |
| AQR CAPITAL MANAGEMENT LLC | 716,246 | $20.1M | 1.22% |
| CITADEL ADVISORS LLC | 677,623 | $19.0M | 1.16% |
| Bridgewater Associates, LP | 251,506 | $7.0M | 0.43% |
| D. E. Shaw & Co., Inc. | 101,427 | $2.8M | 0.17% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.